Gland Pharma Ltd EPS

Gland Pharma Ltd EPS

Image

Gland Pharma Ltd

NSE: GLAND

EPS

₹ 52.45

Last updated on: Feb 20, 2026

Key Highlights

  • The Earning per Share of Gland Pharma Ltd is ₹ 52.45 as of 20 Feb 26 The earning per share of Gland Pharma Ltd changed from ₹ 8.73 to ₹ 15.87 over 7 quarters. This represents a CAGR of 40.71% .

Historical Earning per Share of Gland Pharma Ltd

No data available

* All values are in

Company Fundamentals for Gland Pharma Ltd

Market Cap

30,002 Cr

EPS

52.5

P/E Ratio (TTM)

34.7

P/B Ratio (TTM)

3.1

Day’s High

1836.3

Day’s Low

1815.25

DTE

0.0

ROE

8.3

52 Week High

2130.0

52 Week Low

1200.0

ROCE

12.5

Market Price of Gland Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Gland Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Feb 20261821
19 Feb 20261836.25
18 Feb 20261847
17 Feb 20261833.85
16 Feb 20261809.25
13 Feb 20261779.65
12 Feb 20261815.3
11 Feb 20261866.05
10 Feb 20261883.7
09 Feb 20261885.1

SWOT Analysis Of Gland Pharma Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Gland Pharma Ltd

Asset Value vs Market Value of Gland Pharma Ltd

Market Value

30,002

Asset Value

Value addition

3.4 X

6,853

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Gland Pharma Ltd30002
Sun Pharmaceutical Industries Ltd413753
Divis Laboratories Ltd167032
Torrent Pharmaceuticals Ltd143426
Cipla Ltd108360
Dr Reddys Laboratories Ltd106859

Historical Market Cap of Gland Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Gland Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Gland Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Gland Pharma Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Gland Pharma Ltd News Hub

Gland Pharma slides after Q1 PAT slumps 26% YoY to Rs 144 cr

Revenue from operations jumped 15.97% YoY to Rs 1,401.70 crore in Q1 FY25. Profit before tax (PBT) s

Read more

07 Aug 24

Gland Pharma consolidated net profit declines 25.94% in the June 2024 quarter

Net profit of Gland Pharma declined 25.94% to Rs 143.76 crore in the quarter ended June 2024 as agai

Read more

06 Aug 24

US FDA issues 3 Form 483 observations to Gland Pharma's Pashamylaram facility

The said inspection was conducted between 25 July 2024 and 02 August 2024. The said inspection was c

Read more

05 Aug 24

Gland Pharma Ltd gains for third straight session

Gland Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 1936.35, up 1

Read more

09 Sept 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Oct 2022

PPT

July 2022

TranscriptPPT

FAQs for EPS of Gland Pharma Ltd

What is the EPS of Gland Pharma Ltd stock?

The Earnings Per Share (EPS) of Gland Pharma Ltd is 52.45. An EPS is the amount of net income attributed to each share of a common stock.

How is Gland Pharma Ltd EPS calculated?

The EPS of Gland Pharma Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Gland Pharma Ltd report its EPS?

Gland Pharma Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Gland Pharma Ltd EPS?

Factors that influence the EPS of Gland Pharma Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Gland Pharma Ltd EPS growth indicate future performance?

Yes, consistent growth in Gland Pharma Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions